Renzapride
Sponsors
Alizyme
Conditions
Constipation-Predominant Irritable Bowel SyndromeIrritable Bowel Syndrome
Phase 3
Investigation of the Safety and Efficacy of Renzapride in Constipation Predominant Irritable Bowel Syndrome (IBS)
CompletedNCT00268879
Start: 2005-12-31End: 2008-01-31Updated: 2008-02-15
Long-Term Safety of Renzapride in Women With Constipation-Predominant Irritable Bowel Syndrome (IBS-C)
TerminatedNCT00607971
Start: 2006-04-30End: 2008-06-30Updated: 2008-07-08